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Introduction
Endoplasmic reticulum (ER) in eukaryotic cells is responsible for the early steps in the maturation of most proteins in the secretory pathway, such as folding of the newly synthesized polypeptide chains and posttranslational modifications that are essential for protein function (Schrö der and Kaufman, 2005) . Nascent polypeptides are translocated to the ER lumen in an unfolded state, where they are processed for folding. However, the function of ER will be disrupted when the inflow of unfolded polypeptide chains exceeds the folding or processing capacity of the ER. This ER stress in turn leads to the activation of a series of adaptive pathways known as unfolded protein response (UPR) to maintain ER homeostasis (Schrö der and Kaufman, 2005; Xu et al., 2005; Wu and Kaufman, 2006; Boyce and Yuan, 2006) . The UPR signaling pathways are transduced by three ER resident transmembrane proteins IRE1 3 , PERK and ATF6 upon activation (Schrö der and Kaufman, 2005) , among which IRE1 functions as an endoribonuclease (RNase) to process XBP1 pre-mRNA to a mature form. In an inactive state, IRE1 is associated with BiP Liu et al., 2003) , a chaperone that can distinguish folded and unfolded proteins. As unfolded proteins accumulate in the ER, BiP is competitively released from IRE1 by the huge excess of unfolded proteins . Consequently, IRE1 is activated and transduces the unfolded protein signal across 0925-4773/$ -see front matter Ó 2007 Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.mod.2007.11.010 the ER membrane. IRE1 is an atypical type I transmembrane protein with serine/threonine kinase (Cox et al., 1993) and RNase activities. It is composed of a luminal domain at the Nterminus responsible for sensing the ER stress signal and C-terminal cytoplasmic kinase and site-specific RNase domains (Schrö der and Kaufman, 2005) . Upon activation, IRE1 oligomerizes and phosphorylates itself and subsequently activates the RNase domain, which removes 23 or 26 bp, respectively, from XBP1 pre-mRNA in metazoans (Shamu and Walter, 1996; Yoshida et al., 2001; Shen et al., 2001; Calfon et al., 2002) or 252 bp from Hac1 pre-mRNA in yeast (Cox and Walter, 1996; Kawahara et al., 1997) . Subsequent ligation of RNA by a tRNA ligase generates a frameshift in the resulting mRNA encoding a functionally active bZIP transcription factor, which subsequently stimulates the expression of UPR target genes (Schrö der and Kaufman, 2005) . Noteworthy, we recently have shown that during gastrula and early neurula stages of Xenopus embryogenesis this frame shift is generated by an alternative mechanism, i.e., the removal of a complete exon (exon 4) that is probably deleted by the conventional splicing machinery within the nucleus (Cao et al., 2006a) . The activated isoforms of these proteins either help to restore ER homeostasis and hence the physiological function of cells by increasing the folding capacity of cells, or induce cells to undergo apoptosis when the effort for restoration of ER homeostasis is in vain. Previous studies using induced ER stress conditions underlined that the IRE1/XBP1/ Hac1 signaling pathway plays an essential role for the UPR in eukaryotic organisms such as yeast (Cox and Walter, 1996; Kawahara et al., 1997) , Caenorhabditis elegans (Shen et al., 2001; Calfon et al., 2002) , Drosophila (Ryoo et al., 2007; Plongthongkum et al., 2007) and mammals. However, little information is available about the function of the IRE1/XBP1 pathway during embryogenesis, although loss of function studies revealed that IRE1 or XBP1 are absolutely required for embryonic development of C. elegans (Shen et al, 2001) , Drosophila (Souid et al., 2007) or mouse (Reimold et al., 2000; Urano et al., 2000; Lee et al., 2002) . During Xenopus early embryogenesis, XBP1 is involved in the formation of the mesodermal germ layer (Zhao et al., 2003; Cao et al., 2006a) . We therefore have investigated the function of the IRE1/XBP1 pathway and the relationship between the passive and active isoforms of XBP1 in embryonic development. In the present study, we show that the IRE1 homologues in Xenopus, xIRE1a and b, are differentially expressed during embryogenesis. Both, gain and loss of function analyses revealed that xIRE1b is required for cytoplasmic splicing of xXBP1 pre-mRNA, reflecting the conservation of IRE1/XBP1 pathway in Xenopus. In animal cap assays, we found that overexpression of xIRE1b and xXBP1 pre-mRNA was able to inhibit mesoderm formation induced by activin A. However, functional knockdown of xIRE1b also blocked mesoderm formation, suggesting that xIRE1b is required for mesoderm formation.
Results

Differential expression of IRE1a and IRE1b in Xenopus
Two forms of IRE1 genes, IRE1a and IRE1b, exist in mammals (Tirasophon et al., 1998; Iwawaki et al., 2001) . Search of Xenopus laevis protein sequence databases revealed an IMAGE clone (Genbank Accession No.: BC073092) coding for a protein of 958 amino acids. Further database searches led to three overlapping ESTs (Accession Nos.: BU908941, BJ064380 and BJ050438) being related but not identical to the IMAGE clone. RT-PCR was performed using primers designed from the EST sequences. The amplified cDNA (1963 bp) contains a partial open reading frame coding for a polypeptide of 653 amino acids. This peptide shares only 50% identity to the Xenopus IMAGE clone, reflecting a more distant relationship. Instead, it exhibits 75% identity to human IRE1a (hIRE1a) (Tirasophon et al., 1998) and only 42% to the human IRE1b (hIRE1b) (Iwawaki et al., 2001) . While the amino acid sequence encoded by the Xenopus IMAGE clone is 55% identical to hIRE1a and 52% to hIRE1b (Fig. 1A and B) , a phylogenetic analysis based on sequence similarities showed that the partial cDNA clone and hIRE1a were grouped together and that the IMAGE clone and hIRE1b were genetically closer (Fig. 1C) . We therefore assigned the partial cDNA as Xenopus IRE1a and the IMAGE clone as Xenopus IRE1b (xIRE1b).
IRE1 proteins consist of conserved domains that are critical for their function (Tirasophon et al., 1998; Iwawaki et al., 2001) . At the amino-terminus and the middle of the proteins there are two short regions that represent the putative signal peptide and the transmembrane region, separately (Fig. 1A) . Between the two regions is the ER-luminal domain that locates in the lumen of endoplasmic reticulum. The remaining part between the transmembrane region and the C-terminus is predicted to be the cytoplasmic domain, which is composed of kinase and RNase subdomains (Fig. 1A) .
We have examined the temporal and spatial expression patterns of xIRE1a and xIRE1b during Xenopus embryogenesis. Real-time RT-PCR demonstrated that both, xIRE1a and xIRE1b were already detected in fertilized eggs, showing that they are maternally expressed ( Fig. 2A) . Both transcripts persist during early cleavage stages. From the start of zygotic transcription, they gradually diminish until hatching tadpole stages, when their expression level is slightly increased (Fig. 2A) . These results show that the temporal expression patterns of xIRE1a and xIRE1b are very similar. We next asked how the IRE1 genes are spatially expressed during embryogenesis. Whole mount in situ hybridization revealed that xIRE1a and xIRE1b are expressed in a similar pattern from egg to gastrulation. Transcripts of both, xIRE1a and xIRE1b, were detected in the animal half of fertilized eggs and early cleavage stage embryos (Fig. 2B , C, H and I). During gastrulation, both transcripts are present in the animal and equatorial region but are excluded from the yolk plug ( Fig. 2D and J). However, from the onset of neurulation the spatial expression patterns of the two genes differ completely. At stage 15, xIRE1a is localized to the neural plate (Fig. 2E) . In tailbud embryos, xIRE1a was detected in the forebrain, midbrain, hindbrain, eyes, otic vesicles and neural tube ( Fig. 2F and G). Additional expression domains were observed in the brachial arches, pronephric duct and a domain that is probably representing the dorsal pancreas anlage ( Fig. 2F and G). Abundant expression of IRE1a has also been reported for the mammalian pancreas (Tirasophon et al., 1998) . In the case of xIRE1b, transcription is only observed in the hatching gland and cement gland anlagen during neurula stage (Fig. 2K) . These expression domains become more prominent in the hatching embryos and persist until the hatched tad-pole stage ( Fig. 2L and M) . Therefore, the different localization of xIRE1a and xIRE1b transcripts after gastrulation suggests that they might play distinct roles in embryonic development.
IRE1 is an unconventional ribonuclease that cleaves XBP1 pre-mRNA to generate a mature mRNA that codes for a functionally active transcription factor in the unfolded protein response. It is thus interesting to compare the spatial expression between xIRE1 and xXBP1, the presumable substrate of xIRE1 enzyme. Before neurulation, expression of xIRE1 overlaps with that of xXBP1 in the animal and equatorial regions excluding the neural ectoderm, where xXBP1 transcripts are not present (Zhao et al., 2003) . At neurula stage, expression of xXBP1 resembles more that of xIRE1b than that of xIRE1a because of the significant overlap of expression domains in the hatching gland and the cement gland. However, localization of xXBP1 in the pronephros, eyes and otic vesicles at tailbud stages is similar to that of xIRE1a, although xXBP1 transcripts are not present in the forming nervous system (Zhao et al., 2003) . Such a correlation between the spatial expression domains of xIRE1 and xXBP1 suggests that cytoplasmic processing of xXBP1 pre-mRNA in different regions of early embryos might be accomplished by different forms of xIRE1 enzymes.
xIRE1b gain of function
Since xIRE1a and xIRE1b share identical expression patterns until neurulation and the complete coding sequence of xIRE1a is so far not available, we have focused on the role of xIRE1b during Xenopus germ layer formation by gain of function (GOF) experiments. Different doses of xIRE1b mRNA were injected into all blastomeres at 4-cell stage. Even at a dose of 1.5 ng, injected embryos at tailbud stage were nearly normal with only slight shortening of anterior-posterior (A-P) body axis (Fig. 3B ). Whole mount in situ hybridization of embryos injected with 1.5 ng xIRE1b revealed that the expression of the pan-mesodermal marker gene Xbra and the endodermal gene Xsox17a at stage 10.5 was not significantly changed as compared to uninjected control embryos ( Fig. 3C  and D) . Therefore, GOF of IRE1b did obviously not lead to an apparent change of phenotype and we did not observe a significant change of mesodermal and endodermal marker gene expression. IRE1 proteins play critical roles in the regulation of gene expression mediated by unfolded protein response (UPR). Since cleavage of XBP1 pre-mRNA by IRE1 is a well conserved mechanism throughout all organisms examined (Sidrauski and Walter, 1997; Yoshida et al., 2001; Calfon et al., 2002) , we tested if the IRE1 homologue xIRE1b could also cleave Xenopus XBP1 pre-mRNA, xXBP1(U). Uninjected control and xIRE1b injected embryos were collected at stages 11, 15 and 25 and subjected to real-time RT-PCR. As previously reported for uninjected embryos at stage 11, only the unspliced (xXBP1(U)) and the conventional nuclear splice form of xXBP1 (xXBP1(N)) were detected (Cao et al., 2006a) . In embryos injected with xIR- E1b, an additional band representing the active cytoplasmic splice variant of xXBP1 (xXBP1(C)) was detected ( Fig. 3E ). At stages 15 and 25, xXBP1(C) was significantly increased concomitant with a decrease of xXBP1(U) in comparison to the controls. Therefore, overexpression of xIRE1b enhances cytoplasmic splicing of xXBP1 pre-mRNA.
Previous studies had shown that overexpression of either the active isoforms, xXBP1(C) or xXBP1(N), inhibited formation of mesoderm and caused strong phenotypic alterations (Zhao et al., 2003; Cao et al., 2006a ). This appears to be incongruent with the present observation that overexpression of xIRE1b in whole embryos increases the number of xXBP1(C) transcripts but does not generate a significant morphological effect on embryonic development. However, this increase of xXBP1(C) transcript might be not sufficient to affect embryonic morphology. We therefore made use of the more sensitive animal cap assays to test the effect of xIRE1b mediated splicing of xXBP1 on mesoderm differentiation induced by activin A. xXBP1(U) or xXBP1(C) and xIRE1b mRNA was injected alone or together into the animal pole of all blastomeres at the 4-cell stage. Animal caps were removed from uninjected or injected embryos at stage 8.5 and subjected to activin A treatment. As expected, uninjected caps without treatment developed into atypical epidermis ( Fig. 4A ) and those treated Overexpression of the active variants xXBP1(C) and xXBP1(N) strongly upregulated UPR target gene expression, but the unspliced form and xIRE1b did not generate significant effect. In these experiment, 1.5 ng of xIRE1b or each 500 pg of xXBP1 variants was injected.
with activin A at 10 ng/ml showed typical elongations indicating mesoderm formation (Fig. 4B ). In agreement with the observation that overexpression of xIRE1b (Fig. 3B ) or xXBP1(U) (Cao et al., 2006a) have no significant influence on embryonic development, injection of either xIRE1b or xXBP1(U) did also not prevent the elongation of animal caps induced by activin A (Fig. 4C and D) . In contrast, when xIRE1b and xXBP1(U) were injected together, animal caps did not elongate anymore in the presence of activin A, reflecting that its activity was inhibited (Fig. 4E) . This result suggests that the amount of xXBP1(C) generated by exogenous xIRE1b mediated splicing of exogenous xXBP1(U) in the caps was high enough to inhibit the activity of activin A. In line with this, overexpression of xXBP1(C) alone also blocked the activity of activin A in animal caps (Fig. 4F ). This means that the endogenous amount of xXBP1(U) RNA is not sufficient to generate the excess of xXBP1(C) being required for the inhibition of elongation even upon overexpression of xIRE1b . These results were further substantiated by real-time RT-PCR. Although expression of mesodermal differentiation genes a-actin and XMyoD in animal caps upon overexpression of xXBP1(U) or xIRE1b alone was partially reduced, the strongest inhibition of a-actin and XMyoD genes was observed, when xXBP1(U) and xIRE1b were overexpressed together (Fig. 4G) .
As the IRE1/XBP1 pathway plays an essential role in the UPR, we tested the effect of xIRE1b or xXBP1 variants on the expression of UPR target genes. Real-time RT-PCR of embryos at gastrula and neurula stages revealed that expression of three UPR target genes BiP, EDEM and CHOP was not or only slightly altered in response to overexpression of the inactive xXBP1(U) (Fig. 4H) . However, overexpression of both active variants xXBP1(C) and xXBP1(N) led to a dramatic upregulation of these genes. In addition, we did not observe a significant change in gene expression when xIRE1b was overexpressed (Fig. 4H ). This effect may again reflect that the number of endogenous xXBP1(U) transcript is the limiting factor for generating a dramatic change in UPR target gene expression.
xIRE1b loss of function
To further explore the function of xIRE1b during early embryonic development, we performed a loss of function (LOF) analysis by using an antisense morpholino oligonucleotide (IRE1bMO) directed against xIRE1b. First, we tested if IRE1bMO could efficiently block xIRE1b translation in an in vitro transcription/translation system. In this assay, xIRE1b was effectively transcribed/translated from a pCS2+xIRE1b construct, which contains the IRE1bMO binding sequence, or from in vitro synthesized xIRE1b mRNA derived from this construct (Fig. 5A) . In both cases, translation was dramatically decreased by addition of IRE1bMO (Fig. 5A) . We then examined the embryonic phenotype in response to xIRE1b knockdown. While injection of a control morpholino (ctrlMO) at a total of 50 ng into either two dorsal, two ventral or all four blastomeres at 4-cell stage had no effect on embryonic development (Fig. 5B) , ventral injection of 50 ng IRE1bMO caused shortening of posterior structures during tailbud stage (Fig. 5C ). When the same dose of IRE1bMO was injected dorsally, more obvious phenotypes, such as severe shortening of A-P axis, open neural fold and loss of head structures, were observed (Fig. 5D ). We then tried to rescue the xIRE1b morphant using a mutated version of xIRE1b, xIRE1bmut, in which the IRE1bMO binding sequence was mutated while the amino acid sequence remained intact. In vitro translation assays demonstrated that IRE1bMO did not block translation of xIRE1bmut (data not shown). We observed that when xIRE1bmut was applied together with IRE1bMO in two dorsal blastomeres at 4-cell stage, embryos developed with body axis formation and neural fold closure (Fig. 5E) . Therefore, the xIRE1b morphant is specific.
We performed whole mount in situ hybridizations to examine whether mesoderm or endoderm formation was perturbed in the xIRE1b morphant. Regardless of ventral or dorsal injection, expression of Xbra in the injected part of embryo was diminished when control embryos reached stage 10.5 (Fig. 5F ). In contrast, neither dorsal nor ventral injection resulted in a significant change of Xsox17a expression (Fig. 5G) . We subsequently investigated the expression of mesodermal and endodermal marker genes using real-time RT-PCR. At stage 10.5, the expression level of the pan-mesodermal gene Xbra was significantly decreased in embryos after dorsal injection, ventral injection or both (Fig. 5H) . Expression of the dorsal mesodermal gene gsc was strongly reduced in response to dorsal injection or both dorsal and ventral injection of IRE1bMO but not significantly changed with ventral injection. Injection into both dorsal and ventral parts of embryo or ventral injection caused a reduction in the expression of the ventral mesodermal gene Xwnt8, but it was not changed when embryos were injected dorsally (Fig. 5H ). In line with the result obtained by whole mount in situ hybridization, RT-PCR did not detect significant changes in Xsox17a expression (Fig. 5H) . By consequence of the inhibition of early mesodermal genes, the genes marking mesoderm differentiation at tailbud stage, XMyoD and a-actin, were strongly repressed upon ventral injection of IRE1bMO, dorsal injection or both, but endodermin, a gene denoting endoderm differentiation, was not remarkably changed (Fig. 5H) .
We subsequently tested the effect of xIRE1b knockdown on mesoderm differentiation induced by activin. While animal caps treated with activin A revealed typical elongation due to mesoderm differentiation, no elongation occurred in caps injected with IRE1bMO (Fig. 6A) . Analysis of mesodermal marker genes confirmed that mesoderm formation was indeed blocked by xIRE1b knockdown (Fig. 6A) . In summary, these data reflect that a functional knockdown of xIRE1b caused the failure of mesoderm formation during embryogenesis.
2.4.
xIRE1b is required for the cytoplasmic splicing of xXBP1 pre-mRNA and for the expression of UPR-mediated genes
The purified cytoplasmic domain of either mammalian IRE1a or IRE1b is sufficient to cleave XBP1 pre-mRNA , suggesting that the two proteins have an identical function in cytoplasmic splicing of XBP1. To determine if IRE1b is also required for cytoplasmic splicing of XBP1, we analyzed cleavage of xXBP1 pre-mRNA in xIRE1b knockdown embryos. Embryos injected with IRE1bMO were collected at gastrula and neurula stages. RT-PCR showed that, in contrast to overexpression of xIRE1b, cytoplasmic splicing of xXBP1 was decreased in both, gastrula and neurula stage embryos injected with IRE1bMO (Fig. 6B) . When IRE1bMO was injected together with xIRE1b mRNA, xXBP1 splicing was replenished, suggesting that blockage of splicing by IRE1bMO is specific (Fig. 6B) . We hence conclude that xIRE1b is involved in cytoplasmic splicing of xXBP1. We next tested if xIRE1b is required for the expression of UPR-mediated genes. Real-time RT-PCR demonstrated that the expression of CHOP, BiP and EDEM was significantly reduced in neurula stage embryos in response to xIRE1b knockdown, and that the reduction in transcription of these genes was reversed when xIRE1b transcript was replenished (Fig. 6C) . Therefore, xIRE1b seems also to be involved in the regulation of UPR-mediated genes in Xenopus. 
2.5.
Specific blocking of cytoplasmic splicing of xXBP1 enhances mesodermal gene expression A total knockdown of all three xXBP1 variants, xXBP1(U), xXBP1(C) and xXBP1(N), by using an antisense morpholino repressing translation of all three isoforms promotes mesoderm formation (Cao et al., 2006a) . However, it is not known whether this effect is specifically due to the knockdown of only the cytoplasmic splice variant xXBP1(C). Therefore, an antisense morpholino oligonucleotide (XBPcytoMO) was designed to block the 3 0 -end site of cytoplasmic splicing such that xIRE1 cannot act on its target sequence on xXBP1(U) (Fig. 7A) . We first examined if XBPcytoMO was able to block splicing of xXBP1(U) in embryos and if blockage of splicing could be reverted by addition of exogenous xIRE1b mRNA. Different dose of XBPcytoMO was injected alone or co-injected with xIRE1b into both blastomeres of 2-cell stage embryos. Controls and injected embryos were collected at neurula stage and xXBP1(C) transcripts were analyzed by RT-PCR. While xXBP1(C) was present in control embryos, it was absent in embryos injected with XBPcytoMO, even at the lowest dose of 10 ng. Further, we observed that cytoplasmic splicing was successfully restored when xIRE1b was co-injected with 10 or 20 ng MO. However, splicing was not restored in embryos injected with 30 ng, suggesting that an excess amount of MO competed with constant amounts of xIRE1b (Fig. 7B ).
The results demonstrate that cytoplasmic splicing was specifically blocked by injection of XBPcytoMO. The failure of splicing also resulted in developmental defects. Embryos injected with 30 ng XBPcytoMO revealed shorter A-P body axis and mild protrusions in the anterior part at tailbud stage (Fig. 7D) . Real-time RT-PCR showed an increase of a-actin and XMyoD expression at tailbud stage (Fig. 7E) . Such a phenotype and the increase of mesodermal differentiation genes are reminiscent of the general knockdown of all xXBP1 variants, in which mesoderm formation is enhanced (Cao et al., 2006a) . We further monitored the effects of xIRE1b as well of XBPcytoMO on xXBP1 splicing using a fluorescence sensor. This UPR sensor was made by fusing the unspliced xXBP1 coding region of aa 121-254 including the stop codon to the 5 0 -end of the coding region of the fluorescent protein, EosFP (Wiedenmann et al., 2004; Cao et al., 2006a) (Fig. 8A) . Without splicing of the 26 nt, the coding region of EosFP is not in frame with xXBP1 and consequently the fluorescent protein will not be expressed. Removal of the 26 nt of intron region will result in a frameshift so that the fluorescent protein can be synthesized. In human cells transfected with xXBP1(U)-EosFP plasmid alone, only weak fluorescence was observed presumably reflecting endogenous IRE1 activity. When xXBP1(U)-EosFP and pCS2+xIRE1b were transfected together, cells revealed much stronger fluorescence (Fig. 8B) , which was also confirmed by quantification (Fig. 8B) . We further tested if the signal can be induced by artificial ER stress. Cells transfected with xXBP1(U)-EosFP and subsequently treated with tunicamycin (TM), an ER stress inducing agent, exhibited also much stronger fluorescence than those cells transfected with the xXBP1(U)-EosFP plasmid but without TM treatment (Fig. 8C) . Additionally, we examined the splicing effect in embryos. In Xenopus embryos, we did not observe apparent green fluorescence after injection of xXBP1(U)-EosFP mRNA. Coinjection of xIRE1b resulted in embryos glowing with green fluorescence (Fig. 8D) . We then injected the embryos with xXBP1(U)-EosFP, xIRE1b and XBPcytoMO together. No obvious fluorescence was detected any more in these embryos (Fig. 8D ). Taken together, the results of these experiments demonstrate that (i) overexpression of xIRE1b is sufficient to induce cytoplasmic splicing of XBP1 pre-mRNA in human cells as well as in Xenopus embryos, (ii) the XBPcytoMO is very effective in blocking XBP1 pre-mRNA cytoplasmic splicing and (iii) specific knockdown of the cytoplasmic splice variant of xXBP1 is sufficient for mesodermal gene activation.
Deletion mutants of xIRE1b have distinct effects on embryonic development
Like its orthologues in other organisms, Xenopus IRE1b is composed of an ER-lumenal domain, a transmembrane domain and a cytoplasmic domain that contains a kinase subdomain and an adjacent ribonuclease subdomain at the C-terminus. To characterize the role of these domains for embryogenesis, two deletion mutants were constructed. One mutant, xIRE1bDC, is composed of the N-terminal part without the C-terminal kinase and RNase domains, and the other, xIRE1bDN, consists of the kinase and RNase subdomains with the signal peptide and the ER-luminal domain truncated (Fig. 9A ). xIRE1bDC and xIRE1bDN RNAs were separately injected into embryos. Injection of xIRE1bDC (Fig. 9C)  or xIRE1bDN (Fig. 9D) caused similar morphological alterations with reduced A-P axis. To characterize whether these similar phenotypes reflect similar alterations in gene expression, we examined the expression of Xbra and Xsox17a by whole mount in situ hybridization. At stage 10.5, expression of Xbra was decreased in embryos injected with xIRE1bDC, but was not significantly changed in those injected with xIRE1bDN (Fig. 9E) . For all cases, no remarkable alteration was observed for the expression of Xsox17a (Fig. 9F) . These results demonstrate that mesoderm formation was inhibited by overexpression of xIRE1bDC but not by xIRE1bDN, while endoderm formation was not affected by any mutant. The effect of xIRE1bDC overexpression is reminiscent of the effect of xIRE1b knockdown, suggesting that xIRE1bDC may work in a dominant-negative fashion by interfering with the function of endogenous xIRE1b. On the other hand, the phenotype of xIRE1bDN overexpression resembles that of wild type xIRE1b, indicating that this mutant might behave similarly to the wild type protein because of the intact kinase and RNase subdomains. This result is also in agreement with the observation that the cytoplasmic domain of mammalian IRE1 cleaves XBP1 pre-mRNA ). Moreover, RT-PCR demonstrated that cytoplasmic splicing of xXBP1 pre-mRNA was inhibited in embryos injected with xIRE1bDC but promoted in those injected with xIRE1bDN (Fig. 9G) . These data further confirm the notion that xIRE1bDC represents a dominant-negative form of xIRE1b.
Finally, we investigated the subcellular localization of xIRE1b and the deletion mutants and their activity in cells. In the experiment, xIRE1b, xIRE1bDC or xIRE1bDN was fused with enhanced green fluorescent protein (EGFP), and the unspliced xXBP1 coding region of aa 121-254 including the stop codon was fused with the red fluorescent protein (RFP) eqFP611 (Wiedenmann et al., 2005) as a sensor for monitoring the splicing activity. HeLa cells were separately transfected with different xIRE1b-EGFP fusion constructs together with the xXBP1(U)-RFP sensor plasmid. We observed a specific distribution of the full-length xIRE1b in cells, most probably representing the localization of endoplasmic reticulum. This pattern of ER was also previously observed in the cells of Arabidopsis (Koizumi et al., 2001) . The presence of red fluorescence reflected the splicing of xXBP1(U) by the full-length xIRE1b (Fig. 9H, upper panel) . xIRE1bDC shows similar localization in cells to that of the wild type protein, however, it has no splicing activity because of absence of red fluorescence (Fig. 9H, middle panel) . In addition, similar localization of xIRE1b and the splicing inactive mutant xIRE1bDC might contribute to the dominant-negative effects of xIRE1bDC (Fig. 9C, E and G) . In contrast, xIRE1bDN was able to activate the xXBP1(U)-RFP sensor but revealed a different subcellular localization in the cells compared to wild type xIRE1b and xIRE1bDC (Fig. 9H, lower panel) .
Discussion
Conservation of IRE1/XBP1 pathway in Xenopus embryos
Mammalian IRE1a and IRE1b show different expression patterns. While IRE1a is expressed ubiquitously in most cells and tissues (Tirasophon et al., 1998) , IRE1b is mainly restricted to intestinal epithelial cells (Wang et al., 1998) . In Xenopus, although IRE1a and IRE1b show similar spatial expression in pre-neurula embryos, they are also differentially expressed following the onset of neurulation. XIRE1a is localized to the nervous system and mesoderm or endoderm-derived organs, such as pronephros and pancreas. In line with this, IRE1a plays an essential role in the regulation of insulin biosynthesis in pancreatic b-cells (Lipson et al., 2006) . In contrast, xIRE1b is only found in hatching and cement glands, two ectoderm-derived organs that are critical for hatching and hatched embryos. Interestingly, the combined spatial expression patterns of xIRE1a and b overlap precisely the spatial distribution of xXBP1 (Zhao et al., 2003) , a known substrate of IRE1 proteins Calfon et al., 2002; Lee et al., 2002) . The co-localization of xIRE1 and xXBP1 transcripts suggests that the IRE1/XBP1 signaling pathway is conserved in Xenopus. Moreover, expression of xIRE1 and xXBP1 in the professional secretory organs that undergo high level of ER stress, like pancreas, cement gland and hatching gland, suggests that the maintenance of ER homeostasis by IRE1/XBP1 signaling is essential to secure proper functions of these organs. By gain of function analysis in Xenopus embryos we observed that xIRE1b enhanced cytoplasmic cleavage of xXBP1 pre-mRNA, suggesting that xIRE1b, like mammalian IRE1a (Back et al., 2006) , cleaves XBP1 pre-mRNA in vivo.
Functional knockdown of xIRE1b led to an inhibition of cytoplasmic splicing of xXBP1 pre-mRNA. Moreover, the inhibitory effect can partially be overcome by adding an excess amount of xIRE1b mRNA. Therefore, xIRE1b is sufficient for xXBP1 cytoplasmic splicing. The results clearly demonstrate a conservation of the IRE1/XBP1 pathway also in Xenopus. The conservation of IRE1b function in Xenopus is also reflected by the fact that it is involved in the expression of UPR-mediated genes such as CHOP, BiP and EDEM, because all these genes were reduced in response to IRE1b functional knockdown. This is in agreement with the observation that overexpression of a dominant-negative form of IRE1 in cells reduced expression of CHOP and BiP (Wang et al., 1998) .
3.2.
IRE1b is required for mesoderm formation
Since xIRE1b cleaves xXBP1 pre-mRNA to generate a splice variant coding for a functionally active transcription factor, we postulated that overexpression of xIRE1b would generate a similar inhibitory effect on mesoderm formation to that observed for overexpression of spliced nuclear or cytoplasmic xXBP1 (xXBP1(N) or xXBP1(C)) (Zhao et al., 2003; Cao et al., 2006a) . However, xIRE1b overexpression resulted only in a weak phenotype lacking any significant decrease of mesodermal and endodermal marker gene expressions. This is probably due to the fact that the amount of xXBP1(C) generated by xIRE1b overexpression is insufficient to produce a strong effect. Actually, animal cap assays support this notion, because elongation of caps by activin A treatment was not blocked by xXBP1(U) or xIRE1b overexpression alone, but was dramatically inhibited by overexpression of xXBP1(U) and xIRE1b together, similar to the inhibitory effect of xXBP1(C) overexpression. The functional knockdown of all three xXBP1 variants (Cao et al., 2006a) or, more specifically, of the cytoplasmic splice variant xXBP1(C), leads to an upregulation of mesodermal marker genes. These analyses demonstrated that xIRE1b, by processing xXBP1 pre-mRNA, regulates or limits the extent of mesoderm formation. Consequently, we would expect an enhanced formation of mesoderm when xIRE1b is functionally knocked down. However, loss of function experiments by using an antisense morpholino oligonucleotide showed a severe reduction in the expression of mesodermal marker genes. The phenotypic alterations of the knockdown phenotype are reminiscent of the embryonic lethal phenotype in IRE1 À/À mice (Urano et al., 2000; Lee et al., 2002) . In support of this, inhibition of mesoderm formation was also observed with a dominant-negative mutant, xIRE1bDC, lacking the cytoplasmic kinase and RNase domains. This apparent discrepancy can not be interpreted by the change in the expression of genes in the UPR pathway like CHOP, since loss of xIRE1b function resulted in decrease of expression of CHOP, which is known to induce apoptosis (Oyadomari and Mori, 2004; Marciniak et al., 2004) and inhibit the Wnt/TCF signaling pathway (Horndasch et al., 2006) . However, IRE1 is not only involved in XBP1 pre-mRNA splicing, generation of active XBP1 and activation of XBP1 target genes. It has been reported, that IRE1 is coupled to the activation of JNK, the c-Jun N-terminal kinase (Urano et al., 2000) . This links IRE1b to the noncanonical Wnt/RhoA signaling pathway and paraxial protocadherins that regulate Xenopus convergent extension movements during gastrulation (Unterseher et al., 2004; Medina et al., 2004; Kim and Han, 2005) . Moreover, the substrate of JNK, c-Jun, is involved in mesoderm formation through the embryonic fibroblast growth factor/Xbra autocatalytic loop (Kim et al., 1998) . Therefore, alternative pathways different from the IRE1/XBP1 pathway could explain for the inhibition of mesodermal gene expression after functional knockdown of xIRE1b. Even if the molecular basis for this relationship remains to be elucidated, our results demonstrate that homeostasis of ER and xIRE1b functions are required for mesodermal germ layer formation in Xenopus embryos.
4.
Experimental procedures
Embryos and animal cap explants
Embryos were obtained with in vitro fertilization and cultured in 0.1· MBSH (1· MBSH: 88 mM NaCl, 2.4 mM NaHCO 3 , 1 mM KCl, 0.82 mM MgSO 4 , 0.41 mM CaCl 2 , 0.33 mM Ca(NO 3 ) 2 , 10 mM HEPES, pH 7.4). Animal cap explants were cut from uninjected or injected embryo at stage 8.5, and cultured until control sibling embryos had reached the desired stages. For activin A (R&D systems) treatment, caps were excised in the same way. After 3 h of treatment, they were then transferred to 0.5· MBSH for continuing culture to desired stages.
Plasmids and constructs
The IMAGE clone (Accession No.: BC073092) that contains the complete open reading frame of xIRE1b was purchased from RZPD (Berlin). To make expression constructs, complete coding region, the N-terminal region (aa 1-549) and the C-terminal (aa 439-958) region of xIRE1b was amplified from the IMAGE clone using PCR and subcloned to the XbaI-SnaBI sites on pCS2+. The resulting constructs were designated as pCS2+xIRE1b, pCS2+xIR-E1bDC and pCS2+xIRE1bDN, respectively. The xIRE1b-specific EGFP and xXBP1(U)-RFP fusion constructs were made by PCR resulting in pcDNA3-xIRE1b-EGFP, pcDNA3-xIRE1bDC-EGFP and pcDNA3-xIRE1bDN-EGFP. A partial xIRE1a cDNA of 1963 bp was amplified from gastrula stage total RNA using primers, forward: 5 0 -TGTCCCTGCCAGAAACACTGC-3 0 ; reverse: 5 0 -GAATGC AAGTA GGAAAGTCCCGA-3 0 . The obtained product was ligated to pDrive vector (Qiagen) and the resulting construct was designated as pDrive-xIRE1a. For monitoring the splicing effect of xXBP1 mRNA in vivo, the coding region of 121-254 aa including the stop codon in the unspliced cDNA was fused to the 5 0 -end of the coding region of EosFP or fused to the 5 0 -end of the coding region of eqFP611 and the resulting constructs were designated as xXBP1(U)-EosFP or xXBP1(U)-RFP. For rescuing xIRE1b knockdown phenotype, a mutated xIRE1b expression plasmid pCS2+xIRE1b mut was constructed. The antisense morpholino oligo (see below) recognition sequence ATGGCTTCATCTTTAGCCTCACCTC in the construct was changed into ATGGCCAGCAGTCTCGCAAGTCCAC, but the coded amino acid sequence was not altered.
4.3.
In vitro RNA synthesis, antisense morpholino oligonucleotides and microinjection Plasmids pCS2+xIRE1b, pCS2+xIRE1bDC, pCS2+xIRE1bDN, pCS2+xIRE1bmut, plasmids containing the unspliced, cytoplasmic spliced and nuclear spliced variants of xXBP1, pCS2+xXBP1(U), pCS2+xXBP1(C) (Cao et al., 2006a) were linearized with NotI. Capped mRNAs for microinjection were synthesized with SP6 mMessage mMachine TM kit (Ambion) and cleaned up with RNeasy kit (Qiagen). pBSK+Xbra was cut with SalI, pCS2+Xsox17a was with ClaI, pDrive-xIRE1a with HindIII and pCS2+XIRE1b was cut with XbaI to make antisense probes for whole mount in situ hybridization.
The antisense morpholino oligonucleotide (Gene Tools) used for xIRE1b functional knockdown (IRE1bMO) was: 5 0 -GAGG TGAGGCTAAAGATGAAGCCAT-3 0 ; an antisense morpholino oligonucleotide designed to inhibit the cytoplasmic splicing of xXBP1 (XBPcytoMO) was: 5 0 -GACATCTGGGCCTGCTCCTGCTGCA-3 0 ; a standard control mopholino oligonucleotide (ctrlMO) was: 5 0 -C CTCTTACCTCAGTTACAATTTATA-3 0 . One and a half nanograms of xIRE1b, 500 pg of xIRE1bDC, 1 ng of xIRE1bDN and 500 pg of xXBP1(C) mRNAs were injected into four blastomeres, 50 ng of IRE1bMO was injected into two dorsal, two ventral or four blastomeres at 4-cell stage for scoring the phenotype, whole mount in situ hybridization and marker gene analysis. To rescue the effect of blocking xXBP1 splicing by IRE1bMO, 1.5 ng of xIRE1b was co-injected with 50 ng of MO. To rescue the effect of blocking xXBP1 splicing by XBPcytoMO, 1.5 ng of xIRE1b RNA was separately co-injected with 10, 20 or 30 ng of MO.
In vitro translation
In vitro protein translation was performed with TNT coupled Reticulocyte Lysate Systems (Promega) to test the efficiency of IRE1bMO for blocking protein translation. 1 lg of pCS2+xIRE1b or pCS2+xIRE1bmut plasmid was used either alone or together with 20 lg IRE1bMO for in vitro translation. Translation products were subjected to SDS-PAGE and autoradiography.
Whole mount in situ hybridization
Whole mount in situ hybridization was performed according to the protocol described elsewhere (Harland, 1991) .
4.6.
Real-time and semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR)
Real-time RT-PCR was performed and primers for a-actin, edd, gsc, Xbra, XMyoD, Xnot, Xsox17a and Xwnt8 were as described previously (Cao et al., 2006b) . Primers used for detecting BiP, CHOP, EDEM, XIRE1a and xIRE1b were listed in Table 1 . Semi-quantitative RT-PCR was used to detect unspliced, cytoplasmic spliced and nuclear spliced variants of xXBP1 transcript according to the method described (Cao et al., 2006a) . PCR products were electrophoretically separated using DNA 1000 kits (series II) on the Bioanalyzer 2100 (Agilent Biotechnologies). The migration of DNA bands run in a mini electrophoresis chip was measured. Strength of bands (measurement of fluorescence signals) reflects the amount of DNA.
4.7.
DNA transfection, tunicamycin treatment, imaging and quantification of fluorescence . After 16 h, HEK-293 cells were transfected with 500 ng of expression plasmids by calcium phosphate coprecipitation. HeLa cells were transfected using the Nanofectin transfection reagent (PAA) according to the manufacturer's instructions. Where required, tunicamycin (Sigma) was added to the medium to a concentration of 5 lg/ml 16 h after transfection. The living cells were analyzed 24 h after transfection using a fluorescence microscope (DMIRB, Leica). Images were taken with a digital camera (C4742, Hamamatsu) using the Openlab software (Improvision). The intensity of fluorescence was analyzed from 25 representative photographs using the ImageJ software (http://rsb.info.nih. gov/ij/). 
